The understanding of how our genetic heritage intersects with the environment to impact brain development, function, plasticity and disease, remains arguably the most complex challenge in all of biology, demanding a comparable complexity in the advanced training of neuroscientists. It is simply not possible for basic neuroscientists to gather all of the tools necessary for a productive career through completion of even the best graduate training program. The doctoral graduate may have only minimal exposure to research projects that target mental illness mechanisms, may have never probed the challenges of modeling a brain disease in an animal model, or may be specialists at a single level of analysis, training that we predict will increasingly fail to support a successful research career. Conversely, clinical trainees regularly learn of the genetic contributions to brain function and disease but often cannot readily engage the process, denying in turn their basic-science peers the opportunity to understand the challenges and benefits inherent in disease-guided research. The Vanderbilt Postdoctoral Training Program in Neurogenomics supports the advanced training of both basic and clinical neuroscientists, providing a coordinated program of mentored research, technical forums, invited lectures and career development workshops throughout the Vanderbilt tenure of the trainee. Building on a significant commitment to neuroscience research and training infrastructure at Vanderbilt University through the Center for Molecular Neuroscience (CMN), we organized our first Neurogenomic training program in 2002 and here submit the program's first renewal application. Our past program offered a somewhat broad base of molecular neuroscience training and successfully recruited and mentored outstanding basic and clinical trainees, including significant attention to trainee diversity and professional development as well as to capture of the full breadth of our mentor base. With our renewal Application, we sustain the general structure of our initial program. However, we make a concerted effort to sharpen our program to provide research and training opportunities that best illustrate and apply the tools of gene-informed neuroscience, spanning invertebrate and vertebrate model systems as well as direct analysis of the human genome, activities that immerse trainees in leading edge neurogenomic models, approaches and technologies. Our program is directed by Randy D. Blakely, Ph.D., Director of the CMN, and an NIMH MERIT awardee, whose research capture opportunities in both nematode and transgenic mouse models to understand the regulation and genetics of biogenic amine signaling, and who has an outstanding track record in both pre- and postdoctoral training. The program is co-directed by James S. Sutcliffe, Ph.D., a talented neurogeneticist, who brings to the program expertise in the study of genes contributing risk to neurobehavioral disorders, including Angelman's syndrome and Autism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Institutional National Research Service Award (T32)
Project #
5T32MH065215-10
Application #
8288828
Study Section
Special Emphasis Panel (ZMH1-ERB-Z (02))
Program Officer
Desmond, Nancy L
Project Start
2002-07-15
Project End
2013-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
10
Fiscal Year
2012
Total Cost
$317,919
Indirect Cost
$25,101
Name
Vanderbilt University Medical Center
Department
Neurosciences
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Jefferson, Angela L; Hohman, Timothy J; Liu, Dandan et al. (2015) Adverse vascular risk is related to cognitive decline in older adults. J Alzheimers Dis 44:1361-73
Shonesy, Brian C; Jalan-Sakrikar, Nidhi; Cavener, Victoria S et al. (2014) CaMKII: a molecular substrate for synaptic plasticity and memory. Prog Mol Biol Transl Sci 122:61-87
Koran, Mary Ellen I; Hohman, Timothy J; Thornton-Wells, Tricia A (2014) Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography. Hum Genet 133:85-93
Koran, Mary Ellen I; Hohman, Timothy J; Meda, Shashwath A et al. (2014) Genetic interactions within inositol-related pathways are associated with longitudinal changes in ventricle size. J Alzheimers Dis 38:145-54
Hohman, Timothy J; Koran, Mary Ellen I; Thornton-Wells, Tricia A et al. (2014) Interactions between GSK3* and amyloid genes explain variance in amyloid burden. Neurobiol Aging 35:460-5
Dickson, Price E; Miller, Mellessa M; Rogers, Tiffany D et al. (2014) Effects of adolescent nicotine exposure and withdrawal on intravenous cocaine self-administration during adulthood in male C57BL/6J mice. Addict Biol 19:37-48
Hohman, Timothy J; Koran, Mary Ellen I; Thornton-Wells, Tricia A et al. (2014) Genetic modification of the relationship between phosphorylated tau and neurodegeneration. Alzheimers Dement 10:637-645.e1
Schmidt, M J; Horvath, S; Ebert, P et al. (2014) Modulation of behavioral networks by selective interneuronal inactivation. Mol Psychiatry 19:580-7
Ye, R; Carneiro, A M D; Airey, D et al. (2014) Evaluation of heritable determinants of blood and brain serotonin homeostasis using recombinant inbred mice. Genes Brain Behav 13:247-60
Conrad, Kelly L; Louderback, Katherine M; Milano, Elana J et al. (2013) Assessment of the impact of pattern of cocaine dosing schedule during conditioning and reconditioning on magnitude of cocaine CPP, extinction, and reinstatement. Psychopharmacology (Berl) 227:109-16

Showing the most recent 10 out of 57 publications